Biotech catalysts

Public drugmakers ranked by their active Phase 3 clinical pipeline, from ClinicalTrials.gov, alongside recent FDA drug recalls from openFDA. A large or growing late-stage pipeline is a forward catalyst; a recent Class I/II recall is a risk flag. 2 of these are also names the PriorMoves 13F model ranks. As of 2026-10-16.

Descriptive context, not a recommendation and not a return claim.